Paid Clinical Trials in Canton, OH
As of September 2026, 150 paid clinical trials are recruiting in Canton, Ohio. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Canton offers studies at sites including Aultman Health Foundation for conditions such as Breast Cancer, Multiple Myeloma, Carcinoma, Non-Small-Cell Lung, Ovarian Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Canton
Trials by drug in Canton
Filter results
Newly added in Canton
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
143 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
GEMINI-NSCLC: NSCLC Biomarker Study
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
Top Research Study Locations in Canton
Researchers run research studies in Canton, OH at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Aultman Health Foundation | Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma | 33 |
| Gabrail Cancer Center | Colorectal Neoplasms, Hematologic Malignancies, Myelofibrosis | 19 |
| Gabrail Cancer Center Research | Myelodysplastic Syndromes, Acute Myeloid Leukemia, Advanced Cancer | 15 |
| Aultman Hospital | Carcinoma, Non-Small-Cell Lung, Lung Cancer, Non-Small Cell Lung Cancer | 10 |
| Cleveland Clinic Mercy Hospital | Stage IVA Prostate Cancer AJCC v8, Acute Myelogenous Leukemia, Breast Cancer | 9 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Gastrointestinal Stromal Neoplasms, Lymphoma, Non-Hodgkin | 7 |
| Gabrail Cancer & Research Center | ALK-Positive Large B-Cell Lymphoma, Acneiform Eruption Due to Chemical, Breast Cancer | 5 |
| Gabrail Cancer Research Center | Solid Tumor, Advanced Cancer, Breast Cancer | 3 |
| NeuroScience Research Center, LLC | OSA, Parkinson Disease, Idiopathic Hypersomnia | 3 |
| Apex Clinical Research Center - Canton | Plaque Psoriasis | 2 |
| Apex Clinical Research Center, LLC | Hidradenitis Suppurativa (HS), Plaque Psoriasis | 2 |
| Gabrail Cancer and Research Center | Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations | 2 |
| Neuro-Behavioral Clinical Research | Bipolar I Disorder, Schizophrenia | 2 |
| NeuroScience Research Center | Focal Epilepsy | 2 |
| Gastroenterology & Hepatology Specialists, Inc. | Ulcerative Colitis, Crohn's Disease | 2 |
| Alkermes Investigational Site | Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2 | 1 |
| Alkermes Investigator Site | Idiopathic Hypersomnia | 1 |
| Aultman Cardiology Clinical Trials | Cardiovascular Disease | 1 |
| Aultman Hospital, Cardiovascular Consultants, Inc | Atherosclerotic Cardiovascular Disease, Obesity, Overweight | 1 |
| Aultman Medical Group | Cancer | 1 |
| Aultman Medical Group Hematology and Oncology | Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 1 |
| Aultman Timken Family Cancer Center | Breast Cancer | 1 |
| Cleveland Clinic - Mercy Hospital | Triple-Negative Breast Cancer | 1 |
| Cleveland Clinic Mercy Hospital Cancer Center | Extensive-stage Small-cell Lung Cancer | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
Active & Upcoming Studies in Canton (2026)
Recruiting trials in Canton grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (86 active studies)
- A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma · Phase 3 · Corbus Pharmaceuticals Inc.
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
Cardiovascular (6 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
Diabetes & metabolic (5 active studies)
- A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar · Phase 3 · Boehringer Ingelheim
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Neurology & pain (5 active studies)
- A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy · Phase 2 · Vima Therapeutics
- A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease · Phase 4 · Impax Laboratories, LLC
Mental health & behavior (2 active studies)
- 52-week Open Label Safety-Tolerability Study · Phase 3 · LB Pharmaceuticals Inc.
- Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. · Phase 2 · LB Pharmaceuticals Inc.
Pediatric (1 active study)
- Study of SGR-1505 in Mature B-Cell Neoplasms · Phase 1 · Schrödinger, Inc.
Common conditions studied in Canton
- Breast Cancer (7 active studies)
- Multiple Myeloma (5 active studies)
- Carcinoma, Non-Small-Cell Lung (4 active studies)
- Ovarian Cancer (4 active studies)
- Stage IV Lung Cancer AJCC v8 (4 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
Leading research sponsors in Canton
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- NRG Oncology
- GlaxoSmithKline
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Canton?
There are approximately 150 recruiting clinical trials in Canton, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Canton pay participants?
Most recruiting trials in Canton compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Canton?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Canton?
The most common conditions under active study in Canton include Breast Cancer (7), Multiple Myeloma (5), Carcinoma, Non-Small-Cell Lung (4), Ovarian Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Canton?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Canton on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Canton?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Canton?
Recruiting research sites in Canton include Aultman Health Foundation, Gabrail Cancer Center, Gabrail Cancer Center Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Canton right now?
The largest active categories in Canton are Cancer & tumors (86), Cardiovascular (6), Diabetes & metabolic (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.